spp most likely as cheaper to deal with (imo) - although not so equitable.
Supporting this - all appears to be going well, or at least as well as late stage biotech's ever go when getting through the regulatory maze prior to production.
I am not an analyst - dyor
- Forums
- ASX - By Stock
- TIS
- a selling opportunity
a selling opportunity, page-7
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TIS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online